Ultrasound-Guided Acupotomy Release With Biomechanical Assessment For Trapezius Myofascial Pain Syndrome
May 29th, 2026
This protocol describes ultrasound‑guided acupotomy release for trapezius myofascial pain syndrome, using shear wave elastography and digital palpation to quantify biomechanical changes. It enables real‑time fascial visualization, precise release, reduced operator dependence, and reproducible metrics, offering a safe, repeatable workflow for clinical practice and mechanistic research.
Our research focus on ultra-guided acupotomy release with biomechanical assessment for trapezius myofascial pain. Existing blind acupotomy lacks objective guidance and precision. This protocol introduces visualized accurate tissue release to improve safety and reproducibility.
To begin, position the patient in a relaxed sitting posture with the back upright and the gaze directed forward. Rest both arms naturally on the anterior thighs and place the feet flat on the floor. Ensure the affected trapezius region is fully exposed.
Ask the patient to identify the most painful area. Then apply a gradual vertical pressure of two to three kilograms within the taut band of the trapezius to locate the maximal tender point. Using a sterile gentian violet skin marker, draw a 0.5 centimeter diameter circle at the target point.
Disinfect the skin with povidone iodine using a circular motion from the center outward. Repeat three times, allowing 30 seconds of drying between applications. Finally, cover the area with a sterile fenestrated drape centered on the marked point.
Next, power on the color Doppler ultrasound system. Connect the high frequency linear array probe of 4 to 18 megahertz and set it to 17 megahertz. Select the MSK extremity preset and enable tissue harmonic imaging.
Set the depth to three to four centimeters, the power to 95%the frame rate to 35 hertz, and the gain to 60 to 70 decibels. Adjust time gain compensation for uniform brightness. Then position the focus at the deep fascia.
Apply two to three milliliters of medical ultrasound coupling gel to the probe surface. Cover the probe with a disposable sterile medical glove. Expel air to create a smooth surface and secure the distal end with two finger stalls.
Disinfect the glove's outer surface with sterile povidone iodine. Instruct the patient to inform the physician immediately of any discomfort during the procedure. Place the ultrasound probe along the direction of the trapezius muscle fibers with the long axis of the probe parallel to the fiber orientation.
Position the probe perpendicularly on the skin over the marked point while maintaining stable probe-to-skin contact with skin indentation less than 0.5 centimeters. Slowly move the probe along the fiber direction to scan and identify areas of locally thickened fascia. Center the thickest part of the thickened fascia under the probe.
Insert the acupotomy needle percutaneously at a 0.0.5 centimeters lateral to the probe long axis marker. Under real-time ultrasound guidance, advance the needle medially to laterally toward the shoulder joint at a 10 to 15 degree angle to the skin, parallel to the trapezius muscle long axis. Guide the needle tip to the superficial fascia layer.
Perform three to five oblique release motions until a palpable loss of resistance is felt or ultrasound shows fascia separation and improved sliding. Withdraw the needle to the subcutaneous level. Adjust the insertion angle to approximately 45 degrees.
And advance the needle tip to the deep fascia layer under ultrasound guidance. Perform three to five oblique release motions with a five millimeter longitudinal movement at a frequency of one hertz until loss of resistance is felt or ultrasound shows fascia separation and improved sliding. Then withdraw the needle completely.
Apply firm pressure to the needle site with a sterile cotton ball for 30 seconds and cover the site with a sterile adhesive dressing. Immediately after the intervention, perform shear wave elastography and digital palpation to quantitatively assess soft tissue biomechanical properties under resting and passive stretching conditions. Finally, assist the patient in adjusting their clothing.
No significant differences were observed among the three groups in baseline characteristics, including sex, age, and body mass index, indicating comparability. In the acupotomy group, visual analog scale scores at both one and two weeks post-treatment were significantly lower than baseline in zero week measurements. The resting state shear wave elastography value decreased significantly immediately post-treatment at zero week compared to baseline and remained significantly lower at one week and two weeks.
In the acupotomy group, muscle tone under both resting and passive stretching states was significantly reduced at one and two weeks compared to zero weeks. Stiffness was significantly reduced at one and two weeks compared to baseline in both resting and passive stretching states. In the acupotomy group, the resting state elasticity at one week was significantly lower than at zero week.
By two weeks, the elasticity in the acupotomy group at rest was significantly lower than at zero weeks and baseline. At the two-week follow-up, elasticity in the acupotomy group under passive stretching was significantly lower than that in the blank control group. This protocol allow researchers to measure soft tissue stiffness, elasticity, and shear wave elastic modulus.
This method can be applied to other myofascial pain sites, such as infraspinatus and quadratus lumborum. Future study can improve baseline matching, extend follow-up duration, and evaluate the protocol's applicability across additional muscle groups and conditions.
Overview
This article presents a standardized protocol for ultrasound-guided acupotomy release in patients with trapezius myofascial pain syndrome (MPS), integrating objective biomechanical assessment methods. The approach aims to improve reproducibility, enable quantitative evaluation of outcomes, and facilitate mechanistic research in the treatment of MPS.
Key Study Components
Area of Science
- Musculoskeletal medicine
- Pain management
- Biomechanics
- Ultrasound imaging
Background
- Trapezius myofascial pain syndrome is a common musculoskeletal disorder.
- Conventional acupotomy release is highly operator-dependent and lacks objective outcome measures.
- There is a need for standardized protocols to improve reproducibility and support mechanistic studies.
- Objective biomechanical assessment can provide quantitative evaluation of treatment effects.
Purpose of Study
- To establish a standardized, ultrasound-guided acupotomy release protocol for trapezius MPS.
- To integrate objective biomechanical assessment using shear wave elastography (SWE) and digital palpation.
- To quantify clinical and biomechanical changes following intervention.
Methods Used
- Standardized patient positioning and ultrasound localization of pathological fascial layers.
- Precise needle insertion and layered superficial/deep fascial release under ultrasound guidance.
- Application of shear wave elastography and digital palpation to assess soft tissue biomechanical properties at rest and during passive stretching.
- Quantitative evaluation of pain (VAS scores), shear modulus (G-value), muscle tone, stiffness, and elasticity at multiple time points post-intervention.
Main Results
- VAS pain scores were significantly reduced at 1 and 2 weeks post-intervention compared to baseline and immediately after treatment.
- Resting-state shear modulus (G-value) improved significantly immediately, at 1 week, and at 2 weeks post-intervention versus baseline.
- Muscle tone and stiffness at rest and during passive stretching, as well as resting elasticity, improved significantly at 1 and 2 weeks compared to immediately after intervention.
- Elasticity at both passive stretching and resting positions was significantly improved at 2 weeks compared to baseline and immediately after intervention.
Conclusions
- The protocol enables reproducible ultrasound-guided acupotomy release for trapezius MPS.
- Objective biomechanical assessment quantifies clinical and tissue-level changes post-intervention.
- This workflow supports standardized clinical practice, technical training, and mechanistic research in acupotomy for MPS.
Frequently Asked Questions
Executive Industry Relevance
Standardizing ultrasound-guided acupotomy release with quantitative biomechanical assessment addresses reproducibility and objective measurement challenges in musculoskeletal intervention research. This protocol enables mechanistic de-risking and supports predictive confidence in early-stage target validation for pain modulation strategies. The workflow's quantitative outputs facilitate portfolio triage and cross-study comparability in translational musculoskeletal R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables objective interrogation of therapeutic hypotheses in myofascial pain syndromes.
- Supports mechanistic de-risking by quantifying tissue-level changes post-intervention.
- Facilitates functional target validation through reproducible biomechanical metrics.
- Provides quantitative endpoints for portfolio triage in pain research pipelines.
Screening & Assay Development
- Establishes validated biomechanical assessment systems for downstream intervention studies.
- Standardizes measurement of muscle tone, stiffness, and elasticity for assay reproducibility.
- Enables quantitative screening of intervention efficacy using shear wave elastography outputs.
- Supports scalable and reusable assessment platforms for musculoskeletal research.
Translational & Preclinical Research
- Aligns biomechanical readouts with disease-relevant endpoints in myofascial pain models.
- Provides continuity from mechanistic discovery to preclinical validation of intervention effects.
- Enables risk-adjusted advancement decisions based on objective tissue response metrics.
- Supports translational biomarker development for musculoskeletal intervention studies.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by providing standardized, quantitative assessment of intervention effects in musculoskeletal models.
- Discovery Biology: Quantitative biomechanical assessment supports hypothesis testing and mechanistic clarification in pain modulation research.
- Screening: Reproducible measurement of tissue properties enables assay readiness and cross-study comparability.
- Analytics: Objective outputs such as shear modulus and elasticity facilitate statistical comparison of intervention conditions.
- Translational Research: Biomechanical endpoints align with disease-relevant outcomes for preclinical validation.
- Enterprise Reuse: The standardized workflow is adaptable for broader musculoskeletal intervention studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in intervention studies.
- Operational Value: Enhances standardization, reproducibility, and scalability of biomechanical assessments.
- Strategic Value: Supports informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of musculoskeletal intervention candidates.
Implementation Considerations
- Requires expertise in ultrasound imaging and biomechanical measurement techniques.
- Needs access to shear wave elastography and digital palpation instrumentation.
- Demands cross-team standardization of patient positioning and measurement protocols.
- Adaptation may be needed for different anatomical sites or musculoskeletal conditions.
- Short-term assessment windows may limit evaluation of long-term intervention effects.
